SuperworthAssembly Biosciences shares outstanding ASMB
Diluted shares outstanding, averaged over each quarter, from 2010.
- Latest quarter, to Jun 30, 2026
- 18.9M
- On a year earlier
- +146.3%
- more shares
Assembly Biosciences had 18.9M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 146.3% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 16.9M | +158% |
| FY2024 | 6.5M | +23% |
| FY2023 | 5.3M | +31% |
| FY2022 | 4.1M | +9% |
| FY2021 | 3.7M | +26% |
| FY2020 | 3M | +29% |
| FY2019 | 2.3M | +9% |
| FY2018 | 2.1M | +34% |
| FY2017 | 1.6M | +10% |
| FY2016 | 1.4M | +0% |
| FY2015 | 1.4M | +64% |
| FY2014 | 876.2K | +152% |
| FY2013 | 347.5K | +61% |
| FY2012 | 215.5K | +4% |
| FY2011 | 206.8K | +996% |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 18.9M | +146% | |
| Q1 FY26 | 16.9M | +125% | |
| Q4 FY25 | 16.9M | +158% | |
| Q3 FY25 | 12.7M | +100% | |
| Q2 FY25 | 7.7M | +36% | |
| Q1 FY25 | 7.5M | +37% | |
| Q4 FY24 | 6.5M | +23% | |
| Q3 FY24 | 6.4M | +45% | |
| Q2 FY24 | 5.6M | +30% | |
| Q1 FY24 | 5.5M | +29% | |
| Q4 FY23 | 5.3M | +31% | |
| Q3 FY23 | 4.4M | +8% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Assembly Biosciences
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.